These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 18713123
21. [Should we modify hemoglobin targets in CKD patients? FDA and EMEA statements]. Martín de Francisco AL, Aljama P, Arias M, Górriz JL, Martínez Castelao A, Portolés J. Nefrologia; 2007; 27(4):399-404. PubMed ID: 17944575 [No Abstract] [Full Text] [Related]
22. Evidence and implications of haemoglobin cycling in anaemia management. Fishbane S, Berns JS. Nephrol Dial Transplant; 2007 Aug; 22(8):2129-32. PubMed ID: 17595177 [No Abstract] [Full Text] [Related]
23. Use of erythropoietin after solid organ transplantation. Schwenger V, Morath C, Zeier M. Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii47-viii49. PubMed ID: 17890262 [Abstract] [Full Text] [Related]
24. Debate: CON Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed? Locatelli F, Del Vecchio L. Am J Nephrol; 2010 Sep; 31(6):557-60; discussion 561-2. PubMed ID: 20501989 [No Abstract] [Full Text] [Related]
25. Editorial perspective. Should hemoglobin targets for anemic patients with chronic kidney disease be changed? Parfrey PS. Am J Nephrol; 2010 Sep; 31(6):565-6. PubMed ID: 20501992 [No Abstract] [Full Text] [Related]
26. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study. Tsuboi M, Ezaki K, Tobinai K, Ohashi Y, Saijo N. Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318 [Abstract] [Full Text] [Related]
27. The KDIGO anemia guideline: can reason triumph over regulation? Wish JB. Nephrol News Issues; 2012 Dec; 26(13):20, 22-3. PubMed ID: 23346853 [No Abstract] [Full Text] [Related]
28. Anaemia in elderly patients. Andrès E, Mecili M. Blood Transfus; 2011 Jan; 9(1):108-9; reply 110-1. PubMed ID: 21084013 [No Abstract] [Full Text] [Related]
32. Managing anemia. What do we do now? Views from Canada. Mendelssohn DC, Muirhead N, Manns BJ. Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988 [No Abstract] [Full Text] [Related]
34. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure? Pagourelias ED, Koumaras C, Kakafika AI, Tziomalos K, Zorou PG, Athyros VG, Karagiannis A. Angiology; 2009 Jun; 60(1):74-81. PubMed ID: 18413330 [Abstract] [Full Text] [Related]
37. Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results. Locatelli F, Covic A, Macdougall IC, Scherhag A, Wiecek A, ORAMA Study Group. J Nephrol; 2009 Jun; 22(5):662-74. PubMed ID: 19810000 [Abstract] [Full Text] [Related]
38. Hepcidin for clinicians. Young B, Zaritsky J. Clin J Am Soc Nephrol; 2009 Aug; 4(8):1384-7. PubMed ID: 19556376 [Abstract] [Full Text] [Related]
39. [Correction of anemia in renal insufficiency: what target?]. Drüeke TB. Nephrol Ther; 2008 Oct; 4 Spec No 2():1-8. PubMed ID: 19000892 [No Abstract] [Full Text] [Related]